MedTrace Logo

Study of Photodynamic Therapy in Patients With Prostate Cancer Following Radiation Therapy

NCT00308919 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2010-06-22

No results posted yet for this study

Summary

To assess by MR Imaging the lesions induced by WST09-mediated photodynamic therapy (PDT) in patients with recurrent or persistent localized prostate cancer following definitive radiotherapy using different light doses and multiple illuminating fibres.

Conditions

  • Recurrent or Persistent Localized Carcinoma of the Prostate Following Radiation Therapy Failure

Interventions

DRUG

WST09

Treatment with WST09 Vascular Photodynamic therapy

Sponsors & Collaborators

  • University Health Network, Toronto

    collaborator OTHER

  • STEBA France

    lead INDUSTRY

Principal Investigators

  • John Trachtenberg, MD · University Health Network, Toronto

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-04-30
Completion
2005-11-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00308919 on ClinicalTrials.gov